Possible impacts of new accuracy standards of self-monitoring of blood glucose

US Endocrinology

Volumn 9, Issue 1, 2013, Pages 16-19

  Garg, Satish K ^a   Reed, Kathryne ^a   Grey, Jessica ^a   Westerman, Alex ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Accuracy; ISO 15197; Performance; Self monitoring of blood glucose; Type 1 diabetes; Type 2 diabetes

Indexed keywords

EID: 84879258345     PISSN: 17583918     EISSN: 17583926     Source Type: Journal    
DOI: 10.17925/use.2013.09.01.16     Document Type: Article

References (57)

1. International Diabetes Federation, IDF Diabetes Atlas, 2012 Update, Brussels, Belgium, 2012.
2. International Diabetes Federation, Diabetes Atlas. The Global Burden. Available at: http://www.idf.org/diabetesatlas/5e/theglobal- burden (accessed March 7, 2013).
3. American Diabetes Association, Economic Costs of Diabetes in the U.S. in 2012, Diabetes Care, 2013; Epub ahead of print.
4. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 1993;329:977-86.
5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, Nathan DM, Cleary PA, et al., Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 2005;353:2643-53.
6. Hansen MV, Pedersen-Bjergaard U, Heller SR, et al., Frequency and motives of blood glucose self-monitoring in type 1 diabetes, Diabetes Res Clin Pract, 2009;85:183-8.
7. Wood JR, Miller KM, Maahs DM, et al., Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines, Diabetes Care, 2013; Epub ahead of print.
8. Garg S, Self-monitoring of blood glucose (SMBG), continuous glucose monitoring (CGM), and hemoglobin A1c among T1D Exchange Clinic Registry participants, Presented at: the 5th International Conference on Advanced Technologies & Treatment for Diabetes; Barcelona, Spain, February 8-11, 2012.
9. Miller KM, Beck RW, Bergenstal RM, et al., Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1C Levels in T1D Exchange Clinic Registry Participants, Diabetes Care, 2013; Epub ahead of print.
10. Kempf K, Kruse J, Martin S, ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus, Diabetes Technol Ther, 2010;12:547-53.
11. Davidson MB, Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck, Rev Recent Clin Trials, 2010;5:138-42.
12. Clar C, Barnard K, Cummins E, et al., Self-monitoring of blood glucose in type 2 diabetes: systematic review, Health Technol Assess, 2010;14:1-140.
13. Cameron C, Coyle D, Ur E, Klarenbach S, Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin, CMAJ, 2010;182:28-34.
14. Bonomo K, De Salve A, Fiora E, et al., Evaluation of a simple policy for pre- and post-prandial blood glucose selfmonitoring in people with type 2 diabetes not on insulin, Diabetes Res Clin Pract, 2010;87:246-51.
15. Weber C, Kocher S, Neeser K, Bartaskova D, Impact of selfmeasurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective, Curr Med Res Opin, 2010;26:289-96.
16. Tunis SL, Minshall ME, Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral antidiabetes drugs and with a recent history of monitoring: costeffectiveness in the US, Curr Med Res Opin, 2010;26:151-62.
17. Tunis SL, Willis WD, Foos V, Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain, Curr Med Res Opin, 2010;26:163-75.
18. Benhalima K, Mathieu C, The role of blood glucose monitoring in non-insulin treated type 2 diabetes: what is the evidence?, Prim Care Diabetes, 2012;6:179-85.
19. Murata GH, Duckworth WC, Shah JH, et al., Blood glucose monitoring is associated with better glycemic control in type 2 diabetes: a database study, J Gen Intern Med, 2009;24:48-52.
20. Dallosso HM, Eborall HC, Daly H, et al., Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol, BMC Fam Pract, 2012;13:18.
21. Schwedes U, Siebolds M, Mertes G, Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients, Diabetes Care, 2002;25:1928-32.
22. Guerci B, Drouin P, Grange V, et al., Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto- Surveillance Intervention Active (ASIA) study, Diabetes Metab, 2003;29:587-94.
23. Barnett AH, Krentz AJ, Strojek K, et al., The efficacy of selfmonitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallelgroup, 6-month evaluation (DINAMIC 1 study), Diabetes Obes Metab, 2008;10:1239-47.
24. Polonsky WH, Fisher L, Schikman CH, et al., Structured selfmonitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study, Diabetes Care, 2011;34:262-267.
25. Davidson MB, Castellanos M, Kain D, Duran P, The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial, Am J Med, 2005;118:422-5.
26. Farmer A, Wade A, Goyder E, et al., Impact of self monitoring of blood glucose in the management of patients with noninsulin treated diabetes: open parallel group randomised trial, BMJ, 2007;335:132.
27. O'Kane MJ, Bunting B, Copeland M, Coates VE, Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial, BMJ, 2008;336:1174-7.
28. Allemann S, Houriet C, Diem P, Stettler C, Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis, Curr Med Res Opin, 2009;25:2903-13.
29. St John A, Davis WA, Price CP, Davis TM, The value of selfmonitoring of blood glucose: a review of recent evidence, J Diabetes Complications, 2010;24:129-41.
30. American Diabetes Association, Standards of medical care in diabetes-2013, Diabetes Care, 2013;36 Suppl. 1:S11-S66.
31. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA, Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems, Diabetes Technol Ther, 2009;11:65-72.
32. Blevins TC, Bode BW, Garg SK, et al., Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring, Endocr Pract, 2010;16:730-45.
33. Bergenstal RM, Ahmann AJ, Bailey T, et al., Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP), Diabetes Technol Ther, 2013;15(3):198-211.
34. Garg SK, Hirsch IB, Self-monitoring of blood glucose, Int J Clin Pract Suppl, 2011:1-9.
35. Hirsch IB, Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist, J Clin Endocrinol Metab, 2009;94:2232-8.
36. Ginsberg BH, Factors affecting blood glucose monitoring: sources of errors in measurement, J Diabetes Sci Technol, 2009;3:903-13.
37. Krouwer JS, Cembrowski GS, A review of standards and statistics used to describe blood glucose monitor performance, J Diabetes Sci Technol, 2010;4:75-83.
38. American Diabetes Association, Consensus statement on self monitoring of blood glucose, Diabetes Care, 1987;10:93-9.
39. American Diabetes Association, Self-monitoring of blood glucose, Diabetes Care, 1996;19:S62-S66.
40. International Organization for Standardization, ISO 15197. In vitro diagnostic test systems - Requirements for bloodglucose monitoring systems for self-testing in managing diabetes mellitus, May 2003.
41. International Organization for Standardization, In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Reference number ISO/FDIS 15197, 2013.
42. Ginsberg BH, We need tighter regulatory standards for blood glucose monitoring, but they should be for accuracy disclosure, J Diabetes Sci Technol, 2010;4:1265-8.
43. Freckmann G, Baumstark A, Jendrike N, et al., System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197, Diabetes Technol Ther, 2010;12:221-31.
44. Zueger T, Schuler V, Stettler C, et al., Assessment of three frequently used blood glucose monitoring devices in clinical routine, Swiss Med Wkly, 2012;142:w13631.
45. Tack C, Pohlmeier H, Behnke T, et al., Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a European multicenter study with 453 subjects, Diabetes Technol Ther, 2012;14:330-37.
46. Kimberly MM, Vesper HW, Caudill SP, et al., Variability among five over-the-counter blood glucose monitors, Clin Chim Acta, 2006;364:292-7.
47. Chen ET, Nichols JH, Duh SH, Hortin G, Performance evaluation of blood glucose monitoring devices, Diabetes Technol Ther, 2003;5:749-68.
48. Lippi G, Salvagno GL, Guidi GC, et al., Evaluation of four portable self-monitoring blood glucose meters, Ann Clin Biochem, 2006;43:408-413.
49. Freckmann G, Schmid C, Baumstark A, et al., System accuracy evaluation of 43 blood glucose monitoring systems for selfmonitoring of blood glucose according to DIN EN ISO 15197, J Diabetes Sci Technol, 2012;6:1060-75.
50. Kuo CY, Hsu CT, Ho CS, et al., Accuracy and precision evaluation of seven self-monitoring blood glucose systems, Diabetes Technol Ther, 2011;13:596-600.
51. Damiano ER, El-Khatib FH, Zheng H, et al., A comparative effectiveness analysis of three continuous glucose monitors, Diabetes Care, 2013;36:251-9.
52. Leelarathna L, Nodale M, Allen JM, et al., Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems, Diabetes Technol Ther, 2013;15:143-9.
53. Klonoff DC, The Food and Drug Administration is now preparing to establish tighter performance requirements for blood glucose monitors, J Diabetes Sci Technol, 2010;4:499-504.
54. Walsh J, Roberts R, Vigersky RA, Schwartz F, New Criteria for Assessing the Accuracy of Blood Glucose Monitors meeting, October 28, 2011, J Diabetes Sci Technol, 2012;6:466-74.
55. Heinemann L, (Analytical) Accuracy of Blood Glucose Meters and Patients: How Do They Come Together?, J Diabetes Sci Technol, 2013;7:1-3.
56. Serrano K, FDA Supports Standardized Reporting and Analysis on CGM Devices, Diabetes Technol Ther, 2013;15:348.
57. Centers for Medicare & Medicaid Services, Expansion of competitive bidding program will increase competition, maintain quality, and save medicare billions. Available at: http://www.cms.gov/apps/media/press/factsheet.asp?Counter=4513&intNumPerPage=10&checkDate=&checkKey=&srchType=1&numDays=3500&srchOpt=0&srchData=&keywordTyp e=All&chkNewsType=6&intPage=&showAll=&pYear=&year=& desc=&cboOrder=date (accessed March 15, 2013).